Neurosurgeons' opinions on the prenatal management of myelomeningocele.

CNS = Congress of Neurological Surgeons ISPN = International Society for Pediatric Neurosurgery MMC = myelomeningocele MOMS = Management of Myelomeningocele Study fetal surgery meningomyelocele spina bifida survey

Journal

Neurosurgical focus
ISSN: 1092-0684
Titre abrégé: Neurosurg Focus
Pays: United States
ID NLM: 100896471

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 31 05 2019
accepted: 30 07 2019
entrez: 2 10 2019
pubmed: 2 10 2019
medline: 25 9 2020
Statut: ppublish

Résumé

Improvements in imaging and surgical technological innovations have led to the increasing implementation of fetal surgical techniques. Open fetal surgery has demonstrated more favorable clinical outcomes in children born with open myelomeningocele (MMC) than those following postnatal repair. However, primarily because of maternal risks but also because of fetal risks, fetal surgery for MMC remains controversial. Here, the authors evaluated the contemporary management of MMC in the hope of identifying barriers and facilitators for neurosurgeons in providing fetal surgery for MMC. An online survey was emailed to members of the Congress of Neurological Surgeons (CNS) and the International Society for Pediatric Neurosurgery (ISPN) in March 2019. The survey focused on 1) characteristics of the respondents, 2) the practice of counseling on and managing prenatally diagnosed MMC, and 3) barriers, facilitators, and expectations of fetal surgery for MMC. Reminders were sent to improve the response rate. A total of 446 respondents filled out the survey, most (59.2%) of whom specialized in pediatric neurosurgery. The respondents repaired an average of 9.6 MMC defects per year, regardless of technique. Regardless of the departments in which respondents were employed, 91.0% provided postnatal repair of MMC, 13.0% open fetal repair, and 4.9% fetoscopic repair. According to the surgeons, the most important objections to performing open fetal surgery were a lack of cases available to become proficient in the technique (33.8%), the risk of maternal complications (23.6%), and concern for fetal complications (15.2%). The most important facilitators according to advocates of prenatal closure are a decreased rate of shunt dependency (37.8%), a decreased rate of hindbrain herniation (27.0%), and an improved rate of motor function (18.9%). Of the respondents, only 16.9% agreed that open fetal surgery should be the standard of care. The survey results showed diversity in the management of patients with MMC. In addition, significant diversity remains regarding fetal surgery for MMC closure. Despite the apparent benefits of open fetal surgery in selected pregnancies, only a minority of centers and providers offer this technique. As a more technically demanding technique that requires multidisciplinary effort with less well-established long-term outcomes, fetoscopic surgery may face similar limited implementation, although the surgery may pose fewer maternal risks than open fetal surgery. Centralization of prenatal treatment to tertiary care referral centers, as well as the use of sophisticated training models, may help to augment the most commonly cited objection to the implementation of prenatal closure, which is the overall limited caseload.

Identifiants

pubmed: 31574464
doi: 10.3171/2019.7.FOCUS19362
pii: 2019.7.FOCUS19362
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E10

Auteurs

Pravesh S Gadjradj (PS)

1Department of Neurosurgery, Leiden University Medical Center, Leiden.

Jochem K H Spoor (JKH)

2Department of Neurosurgery, Erasmus University Medical Center Rotterdam.

Alex J Eggink (AJ)

3Department of Obstetrics and Gynaecology, Division of Obstetrics and Fetal Medicine, Erasmus University Medical Center Rotterdam.

René Wijnen (R)

4Department of Pediatric Surgery, Erasmus University Medical Center Rotterdam, The Netherlands; and Departments of.

Jena L Miller (JL)

5Gynecology & Obstetrics and.

Mara Rosner (M)

5Gynecology & Obstetrics and.

Mari L Groves (ML)

6Neurosurgery, Johns Hopkins University, Baltimore, Maryland.

Philip L J DeKoninck (PLJ)

3Department of Obstetrics and Gynaecology, Division of Obstetrics and Fetal Medicine, Erasmus University Medical Center Rotterdam.

Biswadjiet S Harhangi (BS)

2Department of Neurosurgery, Erasmus University Medical Center Rotterdam.

Ahmet Baschat (A)

5Gynecology & Obstetrics and.

Marie-Lise van Veelen (ML)

2Department of Neurosurgery, Erasmus University Medical Center Rotterdam.

Tjeerd H R de Jong (THR)

2Department of Neurosurgery, Erasmus University Medical Center Rotterdam.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH